These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24910212)

  • 41. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer.
    Gregory J; Dyer M; Hoyle C; Mann H; Hatswell AJ
    Health Econ Rev; 2020 Apr; 10(1):10. PubMed ID: 32319016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours - an analysis based on the CLARINET study.
    Meng Y; McCarthy G; Berthon A; Dinet J
    Health Qual Life Outcomes; 2017 Jun; 15(1):131. PubMed ID: 28662673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.
    Dakin H; Gray A; Murray D
    Qual Life Res; 2013 Apr; 22(3):683-94. PubMed ID: 22555470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities.
    Blome C; Beikert FC; Rustenbach SJ; Augustin M
    Arch Dermatol Res; 2013 Apr; 305(3):197-204. PubMed ID: 23266843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of Bayesian Markov chain Monte Carlo methods to estimate EQ-5D utility scores from EORTC QLQ data in myeloma for use in cost-effectiveness analysis.
    Kharroubi SA; Edlin R; Meads D; Browne C; Brown J; McCabe C
    Med Decis Making; 2015 Apr; 35(3):351-60. PubMed ID: 25784746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer.
    Jang RW; Isogai PK; Mittmann N; Bradbury PA; Shepherd FA; Feld R; Leighl NB
    J Thorac Oncol; 2010 Dec; 5(12):1953-7. PubMed ID: 21155140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.
    Pickard AS; Shaw JW; Lin HW; Trask PC; Aaronson N; Lee TA; Cella D
    Value Health; 2009 Sep; 12(6):977-88. PubMed ID: 19402850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model.
    Shih CL; Chen CH; Sheu CF; Lang HC; Hsieh CL
    Value Health; 2013; 16(5):848-54. PubMed ID: 23947980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets.
    Lamu AN; Chen G; Gamst-Klaussen T; Olsen JA
    Qual Life Res; 2018 Jul; 27(7):1801-1814. PubMed ID: 29569014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Internal Responsiveness of EQ-5D-5L and EORTC QLQ-C30 in Dutch Breast Cancer Patients during the First Year Post-Surgery: A Longitudinal Cohort Study.
    Vrancken Peeters NJMC; van Til JA; Huberts AS; Siesling S; Husson O; Koppert LB
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
    Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM
    Value Health; 2011; 14(5):732-9. PubMed ID: 21839412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping between headache specific and generic preference-based health-related quality of life measures.
    Khan K; Mistry H; Matharu M; Norman C; Petrou S; Stewart K; Underwood M; Achana F
    BMC Med Res Methodol; 2022 Oct; 22(1):277. PubMed ID: 36289468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches.
    Khan I; Morris S
    Health Qual Life Outcomes; 2014 Nov; 12():163. PubMed ID: 25388439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea.
    Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS
    Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
    Hernández Alava M; Wailoo AJ; Ara R
    Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping onto Eq-5 D for patients in poor health.
    Versteegh MM; Rowen D; Brazier JE; Stolk EA
    Health Qual Life Outcomes; 2010 Nov; 8():141. PubMed ID: 21110838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.